sub:assertion {
d:DB00602 v:identifier "DB00602" ;
v:namespace "drugbank" ;
v:uri "http://bio2rdf.org/drugbank:DB00602" ;
v:x-identifiers.org <
http://identifiers.org/drugbank/DB00602> ;
dv:drugbank-id "APRD01058" , "DB00602" ;
dv:x-ahfs <
http://bio2rdf.org/ahfs:8:08> ;
dv:x-atc <
http://bio2rdf.org/atc:P02CF01> ;
dv:x-cas <
http://bio2rdf.org/cas:70288-86-7> ;
dv:x-chemspider <
http://bio2rdf.org/chemspider:24605910> ;
dv:x-dpd <
http://bio2rdf.org/dpd:2248882> ;
dv:x-kegg <
http://bio2rdf.org/kegg:C07970> , <
http://bio2rdf.org/kegg:D00804> ;
dv:x-ndc <
http://bio2rdf.org/ndc:0006-0032-20> ;
dv:x-pharmgkb <
http://bio2rdf.org/pharmgkb:PA450133> ;
dv:x-pubchemcompound <
http://bio2rdf.org/pubchem.compound:46936176> ;
dv:x-pubchemsubstance <
http://bio2rdf.org/pubchem.substance:46506810> ;
dv:x-wikipedia <
http://bio2rdf.org/wikipedia:Ivermectin> ;
dct:description "Ivermectin is a broad-spectrum anti-parasite medication. It was first marketed under the name Stromectol® and used against worms (except tapeworms), but, in 2012, it was approved for the topical treatment of head lice infestations in patients 6 months of age and older, and marketed under the name Sklice⢠as well. Ivermectin is mainly used in humans in the treatment of onchocerciasis, but is also effective against other worm infestations (such as strongyloidiasis, ascariasis, trichuriasis and enterobiasis)."@en ;
dct:identifier "drugbank:DB00602" ;
dct:title "Ivermectin"@en ;
a dv:Drug ;
rdfs:label "Ivermectin [drugbank:DB00602]"@en ;
rdfs:seeAlso <
http://www.drugbank.ca/drugs/DB00602> , <
http://www.drugs.com/cdi/ivermectin.html> , <
http://www.rxlist.com/cgi/generic3/ivermectin.htm> .
}